Nisa Investment Advisors
NGNE icon

Nisa Investment Advisors’s Neurogene NGNE Stock Holding History

Nisa Investment Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
463
+400
+635% +$11K ﹤0.01% 2360
2026
Q1 		$1.27K Buy
63
+18
+40% +$349 ﹤0.01% 2704
2025
Q4 		$927 Hold
45
– – ﹤0.01% 2723
2025
Q3 		$780 Hold
45
– – ﹤0.01% 2785
2025
Q2 		$673 Sell
45
-1,208
-96% -$19K ﹤0.01% 2820
2025
Q1 		$14.7K Buy
+1,253
New +$21.8K ﹤0.01% 2002
2024
Q4 		– Sell
-26
Closed -$1.09K – 3039
2024
Q3 		$1.09K Buy
+26
New +$1.01K ﹤0.01% 2556

Other funds holding NGNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Nisa Investment Advisors's NGNE Position: Q2 2026 in Review

Nisa Investment Advisors increased its Neurogene (NGNE) stake by 635% in Q2 2026, buying an estimated $11K and bringing the position to 463 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Nisa Investment Advisors first reported a position in NGNE in Q3 2024 and has held it in 7 quarters since. The position peaked at $14.7K in Q1 2025. 32 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Nisa Investment Advisors held 463 shares of Neurogene worth $14.6K as of Q2 2026.
  • Nisa Investment Advisors bought 400 Neurogene shares in Q2 2026, an estimated $11K.
  • Neurogene made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2360 holding.
  • Nisa Investment Advisors first reported a position in Neurogene in Q3 2024 and has held it in 7 quarters since.
  • Nisa Investment Advisors's Neurogene position peaked at $14.7K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.